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Net Sales
(Billions of Dollars)
Basic Net Earnings
(Per Common Share)
Dividends
(Per Common Share)
June ’ June ’
Value of $1,000 Invested 
in P&G Stock in June 1988
(With Dividend Reinvestment)
For Years Ended June 30
Millions of Dollars Except Per Share Amounts   Percent Change
Net Sales $37,154 $35,764 4%
Operating Income 6,055 5,488 10%
Net Earnings 3,780 3,415 11%
Per Common Share
Basic Net Earnings 2.74 2.43 13%
Diluted Net Earnings 2.56 2.28 12%
Dividends 1.01 .90 12%
A B O U T P R O C T E R  &  G A M B L E Deep consumer understanding and leading-edge science and
technologies go hand-in-hand at Procter & Gamble. Every day, the people of P&G work hard to
provide products of superior quality and value – products that improve the lives of consumers around
the world. Procter & Gamble markets approximately 300 brands to nearly five billion consumers,
including Tide, Pampers,Ariel, Crest,Always,Whisper,Vicks, Didronel, Pantene Pro-V, Oil of Olay
and Pringles. P&G employs 110,000 people worldwide, with world and North American head-
quarters in Cincinnati, Ohio, USA, and regional headquarters in Europe,Asia and Latin America.
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4ThermaCare: Ease your pain – with wearable heat
ThermaCare ultra-thin wraps fit comfortably under 
your clothes for soothing heat that helps relieve 
pain all day long.
Dryel: Care for "dry clean only" fabrics – at home
For less than a $1 a garment and about 30 minutes a load, 
Dryel helps clean and freshen wool, rayon, silk and 
other “dry clean only” clothes in your home dryer.
5new to the
Febreze: Clean bad smells out of fabrics – for good
Just spray Febreze on furniture, carpets, rugs, car 
interiors, clothing, even shoes – and odors  trapped 
in fabrics are gone.  
Olean: Enjoy great tasting snacks – with less fat
Our Crisco people came up with a cooking oil that 
fries up great tasting snacks without adding 
any fat or a single calorie. 
The fine mist penetrates fibers, cleaning
away odors as it evaporates.
world brands...
6Pampers: Breakthrough technology
advances baby skin care  With its unique
Gentle Touch Liner, Pampers has 
surpassed competition to become the 
U.S. share leader in premium diapers.  
Crest: Breakthrough ingredient introduced in Crest
Extra Whitening  Its patented, enamel-safe soft 
silica helps remove surface stains to let the natural
whiteness of your teeth shine through.
new to the
brandinnovations
Actonel: New standard of care for Paget’s Disease,
the second most common metabolic bone disorder
FDA approves remission indication with only 1/3
the treatment time of current leading therapies,
moving Actonel closer to regulatory submission 
for osteoporosis. 
Fairy Liquid: First anti-
bacterial dish soap in the
U.K.  Fairy received Royal
Institute of Public Health
and Hygiene certification
for its innovative, germ-
killing property that fights
cross-contamination.  
Nelson Watts, M.D., Director, Osteoporosis Program,     
Emory University, consults with a patient.
7
Pantene Elastesse: First major break-
through in hair spray technology in over 
40 years  The natural, touchable, flexible
hold meets consumer needs and grows 
our global dollar share to #1.
8Financial Results
Financial Review Responsibility for the
Financial Statements
and Report of
Independent
Accountants
Consolidated Financial
Statements
Notes to Consolidated 
Financial Statements
09 18 19 24
A tradition of growth through innovation.
1911: First all-vegetable shortening
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F I N A N C I A L R E V I E W
Results of Operations
The Company achieved record sales, unit volume and
net earnings for the year ended June 30, 1998. Basic
net earnings per common share increased 13% to
$2.74. Worldwide net earnings for the
year were $3.78 billion, an 11% increase
over the prior year earnings of $3.42
billion.
Worldwide net sales for the current
year were $37.15 billion, an increase of
4% on worldwide unit volume growth
of 6%. The difference between the sales
and volume growth rates was primarily
due to weaker currencies in Europe and
Asia. Excluding these impacts, sales
increased 8%.
Worldwide gross margin for the
current year was 43.3% compared to
42.7% in the prior year. The current
year improvement reflects cost savings,
primarily from the Company’s ongoing
simplification and standardization pro-
gram, as ongoing cost savings generated
by the program exceeded the net cost to fund current
year projects.
Worldwide marketing, research and administrative
expenses were $10.04 billion compared to $9.77 billion
in the prior year. This equates to 27.0% of sales,
compared with 27.3% in the prior year. The 3%
increase in total spending was primarily due to
increased marketing support behind new brands, such
as Tampax and Fat Free Pringles, and the expansion of
existing brands into new markets.
Operating income grew 10%, primarily reflecting sales
growth and cost-control efforts. The Company’s net
earnings margin increased from 9.5% to 10.2%, the high-
est level in 57 years.
Interest expense increased 20% to $548 million on
increased debt, due mainly to acquisitions. Other
income, net, which consists primarily of interest and
investment income, contributed $201 million in the
current year. In the prior year, other income, net, was
$218 million.
The Company’s effective tax rate for the year was
33.8% compared to 34.9% in the prior year. The
decline reflects the benefits of lower tax rates in Europe,
increased research and development tax credits in
North America, and continued emphasis on effective
tax planning.
In 1997, the Company completed its $2.4 billion
restructuring program started in 1993, with annual
cost savings in excess of $600 million after tax. The
Company is continuing an ongoing program of
simplification and standardization,
which includes projects to consoli-
date selected manufacturing facilities,
re-engineer manufacturing and distri-
bution processes, redesign organizations,
simplify product line-ups and divest
non-strategic brands and assets. This
program did not have a significant
impact on 1998 net earnings, as the
aggregate pre-tax cost of projects was
offset by gains on sales of non-strategic
brands and other assets. The net cost of
these activities in 1997 was offset by
increased licensing activity in the
Health Care sector.
Net Earnings
(Billions of Dollars)
Net Sales
(Billions of Dollars)
1946: First heavy-duty synthetic laundry detergent10
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The following provides perspective on the year ended June 30,
1997 versus the prior year:
Worldwide net earnings increased 12% to $3.42
billion in 1997. Net earnings for 1996 were $3.05 billion
and included the settlement of the Bankers Trust
lawsuit, profit from the sale of the Company’s share of
a health care joint venture, a reserve for estimated losses
on a supply agreement entered into as part of the previ-
ous divestiture of the commercial pulp business, and
adoption of FASB Statement No. 121 covering recog-
nition of impairment of long-lived assets. If these items
had been excluded from 1996 earnings, the growth rate
for the year ended June 30, 1997 would have been 13%.
Worldwide net sales in 1997 were
$35.76 billion, up 1% from the prior
year on unit volume growth of 3%. The
difference between sales and volume
growth rates was primarily due to
weaker currencies in Europe and Asia.
Worldwide gross margin increased 
to 42.7% from 40.7% in 1996, reflect-
ing cost savings from the Company’s
simplification and standardization efforts
and the continuing benefits of the
restructuring project initiated in 1993.
Worldwide marketing, research and
administrative expenses were 27.3% of
sales compared with 27.0% in 1996,
primarily due to increases in advertising
and research.
Other income, net, was $218 million in 1997. In
1996, other income, net, was $338 million and included
a $120 million benefit from reversing the reserve 
for two interest rate swap contracts
following settlement of a lawsuit
against Bankers Trust; a $185
million gain on the sale of the
Company’s 50% share of a health
care joint venture to its venture
partner; and a $230 million charge
to increase the reserve for estimated
losses on a supply agreement
entered into as part of the previous
sale of the Company’s commercial
pulp business.
Net earnings margin increased
to 9.5% in 1997 from 8.6% in 1996,
reflecting unit volume growth and
continued emphasis on cost control
through the Company’s simplifica-
tion and standardization program.
Financial Condition
Cash flow from operations was
$4.89 billion, $5.88 billion and $4.16 billion in
1998, 1997 and 1996, respectively. Operating cash
flow provided the primary source of funds to finance
operating needs, capital expenditures and the share
repurchase programs. Operating cash flow, combined
with additional borrowings, provided the primary
source of funds to finance current year acquisitions.
Cash and cash equivalents decreased $801 million in
the current year to $1.55 billion, primarily due to
acquisitions and increased capital expenditures.
Capital expenditures were $2.56 billion in 1998,
$2.13 billion in 1997, and $2.18 billion in 1996. Current
year expenditures included capacity expansions in the
paper and food businesses, primarily in tissue and towel
and snacks. Capital expenditures are expected to
increase during the upcoming year, reflecting planned
capacity increases and technological advances, primar-
ily in the paper and laundry businesses.
Total Shareholder Return
Relative to S&P 500
Net Earnings 
Margin %
The Procter & Gamble Company and Subsidiaries
1955: First fluoride toothpaste clinically proven to prevent cavities
The Procter & Gamble Company and Subsidiaries
11
Net cash used for acquisitions completed during
1998 totaled $3.27 billion, the highest level in 
the Company’s history. Acquisitions were largely
concentrated in paper businesses, and included
Tambrands, Inc. and its global leading brand, Tampax,
the Loreto y Peña paper company in Mexico, and the
Ssangyong Paper Company in Korea. The Company
also increased ownership of various ventures in Asia
and Latin America. Current year acquisitions were
funded through a combination of existing cash
balances and the issuance of debt. Net cash used for
acquisition activities in 1997 and 1996 totaled $150
million and $358 million, respectively. The Company
continued to divest certain non-strategic brands in
1998 in order to focus organizational resources on the
Company’s core businesses. The proceeds from these
sales, the most significant of which was Duncan
Hines, and other asset sales, generated $555 million in
cash flow in the current year, compared to $520 mil-
lion and $402 million in 1997 and 1996, respectively.
The Company initiated a share
repurchase program in 1995 which
authorized the Company to purchase
shares annually to mitigate the dilutive
impact of management compensation
programs. The Company also initiated
discretionary buy-back programs to
repurchase additional outstanding shares
of up to $1 billion per year during 1997
and 1998, in addition to purchases made
under the 1995 program. Current year
purchases under the repurchase pro-
grams totaled $1.93 billion compared to
$1.65 billion in the prior year. The
Company has announced plans to
increase and accelerate its discretionary
share repurchase programs in 1999 beyond
its previous annual target of $1 billion.
Common share dividends grew 12% to $1.01
per share in 1998, compared to $.90 and $.80 in
1997 and 1996, respectively. For the coming year, the
annual dividend rate will increase to $1.14 per common
share, marking the forty-third consecutive year of
increased common share dividend payments. Total
dividend payments, to both common and preferred
shareholders, were $1.46 billion, $1.33 billion and 
$1.20 billion in 1998, 1997 and 1996, respectively.
Total debt was up $3.06 billion to $8.05 billion,
primarily due to the issuance of commercial paper to
fund current year acquisitions. 
Long-term borrowing available under the
Company’s shelf registration statement filed in 1995, 
as amended in July 1997, was $2.0 billion at June 30,
1998. Additionally, the Company has the ability to issue
commercial paper at favorable rates.
The following pages provide perspective on the Company’s
geographic operating segments. Geographic segments exclude
corporate items, most notably certain financing and employee
benefit costs, goodwill amortization, segment eliminations
and projects related to the Company’s simplification and
standardization program.
Operating Cash Flow
(Billions of Dollars)
Net Sales by Geographic Region 
(Billions of Dollars)
North America
Europe, Middle 
East and Africa
Asia
Latin America
Corporate
.
.
.
.
.
1956: First scouring cleanser with effective bleaching12
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North America Region
The North America region continued to deliver solid
progress, achieving record sales, unit volume and 
net earnings.
Net sales for the year were $18.46 billion, an
increase of 5% from the prior year level of $17.63
billion, on unit volume growth of 4%.
Net earnings for the region were up 10% to 
$2.47 billion. The region achieved this earnings growth
through increased unit volume, a continued focus on 
cost control through simplification and
standardization, and a lower tax rate,
primarily related to increased research and
development tax credits, partially offset by
increased spending on product initiatives.
Prior year net earnings were $2.25 bil-
lion, which represented a 15% increase
over 1996. Net earnings margin for the
region was 13.4%, compared to 12.8%
and 11.3% in 1997 and 1996, respectively.
The Paper sector led the region’s
current year volume progress, generat-
ing 10% unit volume growth versus the
prior year and delivering over half of
the region’s total unit volume increase.
This unit volume growth was achieved
behind the strength of the feminine
protection business, driven by the
Tambrands acquisition; diapers, due to
initiative programs; and tissue and
towel, as a result of prior year capacity
increases. The Paper sector also led the region’s profit
improvements, driven by volume growth, increased
pricing in tissue and towel, and cost reduction from
the ongoing simplification and standardization
program. In the prior year, operating results were
driven by the diaper category, behind the acquisition
of baby wipes and the introduction of Pampers Baby-
Dry, and by tissue and towel capacity increases.
The Laundry and Cleaning sector was also a strong
contributor to the region’s current year unit volume
progress, with a 3% increase over a strong prior year
base period. The volume gains were
driven by laundry, which also con-
tributed heavily to the sector’s earnings
progress, and by fabric conditioners.
The Food and Beverage sector
achieved 1% unit volume growth in the
current year, despite reduced coffee
volumes resulting from commodity-
based price increases and the sale of
Duncan Hines. The snacks category
posted the highest increase, behind the
launch of Fat Free Pringles. The sector’s
earnings were negatively impacted by the
loss of profit contribution from Duncan
Hines, and by investments in new initia-
tives. In 1997, unit volume growth was
led by the snacks category, which
achieved double-digit growth behind
new production capacity.
Unit volume in the Beauty Care
sector grew 2% during the year, led by hair care and
deodorants. Net earnings for the sector increased over
a strong prior year base, driven by the skin care and
personal cleansing and the cosmetics and fragrances
categories. Earnings growth declined from the double-
digit increases of prior years, due to intense competition
in hair care and deodorants, and increased investments
in the development of future product initiatives.
North America 
Net Earnings
(Millions of Dollars)
North America 
Net Sales
(Billions of Dollars)
1961: First pleasant-to-use shampoo effective against dandruff
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Unit volume in the Health Care sector was down
1%, as volume softness caused by intense competitive
activity in oral care was partially offset by improved
volume in the pharmaceuticals category. The sector’s
unit volume posted a 3% decline in 1997 compared to
1996. Earnings declined in 1998, as the sector con-
tinued to invest in research and development, primarily
in pharmaceuticals, and in marketing support in the
highly competitive oral care category. The sector will
continue to invest heavily in research and development,
with a pipeline for launching new pharmaceutical drugs
in the coming years and a renewed focus on future
innovations in other health care products.
Europe, Middle East and Africa Region
Record unit volume, sales and earnings in the Europe,
Middle East and Africa region were driven by contin-
ued expansion into developing markets, increased pric-
ing, cost improvements and lower tax rates.
Net sales grew 2% to $11.84 billion, on
8% unit volume growth. Excluding the
effects of unfavorable exchange rates,
primarily in Western Europe, sales grew
10%, ahead of volume. During the prior
year, sales increased 1% to $11.59 billion,
which trailed the 7% unit volume growth
rate due to unfavorable exchange rates.
The region’s net earnings progress
continued in the current year, growing 14%
to $1.09 billion. Net earnings in 1997 were
$956 million, a 21% increase over 1996.
Current year earnings growth was driven
by the region’s volume growth, continued
efforts to reduce cost via simplification and 
standardization and lower tax rates, partially offset by
negative exchange impacts. The net earnings margin
progress also continued in the current year to 9.2%,
from 8.3% and 6.9%, in 1997 and 1996, respectively.
Central and Eastern Europe led
the region’s unit volume growth,
with a 25% increase, driven by
growth in emerging markets. This
follows a 42% growth rate in 1997.
Earnings increased as a result of
unit volume growth, reduced costs
and economies of scale, partially
offset by continued investment in
new product initiatives and new
markets to facilitate future growth.
Middle East and Africa, which
includes the region’s snack busi-
ness, increased unit volume 18%
over the prior year base period,
which also generated a double-
digit increase over 1996. Unit
volume progress was broadly based
across countries and key categories,
led by increased snack sales.
Western Europe unit volume increased 2%,
reflecting the net impact of the Tambrands acquisition
and the divestiture of non-strategic local brands,
primarily in health and beauty care. Net earnings
increased well above volume growth, due to cost
savings, primarily in laundry and cleaning products,
and lower tax rates, partially offset by increased
spending to promote new brand launches.
Europe, Middle East 
and Africa 
Net Sales
(Billions of Dollars)
Europe, Middle East
and Africa Net Earnings
(Millions of Dollars)
1961: First successful, mass-marketed disposable diaper14
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Asia Region
The Asia region was negatively impacted by a
general market contraction caused by the currency
and economic crises in Korea and the ASEAN
countries (Thailand, Malaysia, Philippines, Indonesia
and Singapore) and the continuing economic reces-
sion in Japan.
Net sales for the region were $3.45 billion, 3% below
the prior year on 4% unit volume growth. Current year
volume growth was driven by acquisitions, including
Ssangyong, a paper business in Korea, and increased
ownership of a venture in China, which more than
offset volume declines in the rest of the
region. Net sales lagged volume growth
as the impact of improved pricing and
product mix were more than offset by the
impact of unfavorable exchange rate
movements. Excluding adverse exchange
effects, sales grew 10%, primarily due to
pricing aimed at recovering the currency
devaluation effects. In the prior year, net
sales declined 8% to $3.57 billion on a
7% unit volume decline. Excluding
exchange effects in 1997, sales were down
2% versus 1996.
The region’s net earnings were 
$174 million, a 37% decrease from the
prior year. Current year earnings were
impacted by lower sales, increased invest-
ment in new product initiatives and the
currency crisis. The prior year net
earnings of $275 million represented 
a 1% increase over 1996. Net earnings
margin for the current year was 5.0%,
compared to 7.7% in 1997 and 7.0% in 1996. The 1998
margin decline reflects lower sales, exchange impacts
and initiative investments.
Greater China’s unit volume was up 6% versus the
prior year.Volume increases were driven by increased
ownership of a joint venture. Net earnings were
higher as the impact of increased volume was partially
offset by unfavorable sales mix and investment
behind new product introductions.
In Japan, unit volume was relatively flat, reflecting the
continued depressed state of the Japanese economy.
Despite the economic troubles, the Company continued
to invest in new product initiatives and
was successful in increasing market shares
during the second half of the year. Net
earnings were lower due to unfavorable
sales mix, investment in new products
and the weakened yen.
The balance of Asia was positively
impacted by the acquisition of the
Ssangyong Paper Company in Korea.
The increased volume in Korea resulting
from this acquisition more than offset
volume declines brought about by 
the economic crisis. Earnings, however,
declined as a result of the currency crisis.
The Asian markets are expected to
remain weak through at least fiscal 1999.
Because the Asia region accounted for
less than 10% of the Company’s total sales
and 5% of the Company’s total earnings
in fiscal 1998, the economic situation is
not expected to be significant to the Company’s over-
all growth rate for the coming year. While the region is
expected to recover from these difficulties, the depth
and duration of the economic effects are still uncertain.
Latin America Region
Latin America continued its positive trends in net sales
and net earnings, with current year results being driven
by acquisitions and the continued strengthening in
Mexico and Venezuela.
Net sales in the region grew 14% to $2.64 billion on
12% unit volume growth, as pricing outpaced the nega-
tive impact of currency devaluation. Volume gains
resulted from the acquisition of Loreto y Peña, a paper 
Asia Net Sales
(Billions of Dollars)
Asia Net Earnings
(Millions of Dollars)
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company in Mexico, the buy-out of a
paper joint venture in the Southern Cone
(Brazil, Argentina, Chile), the prior year
acquisition of a laundry and cleaning
business in Brazil, and the strengthening
of the base business in Mexico, Venezuela
and Argentina. In the prior year, sales for
the region grew 6% to $2.31 billion,
while unit volume was down 2%, reflect-
ing inflation-driven pricing action. In
Mexico, the Company’s largest operation
in the region, business results were strong.
Unit volume increased 16%, behind the
acquisition of the Loreto y Peña paper
company and a general economic recov-
ery in the market.
Net earnings for the region were 
$274 million, a 7% increase. Current year
earnings lagged behind sales growth due
to increased investment to support brand expansion in
the Southern Cone. Excluding these geographies, the
balance of the region’s earnings grew in double digits.
Prior year net earnings were $256 million, a 17%
increase over 1996. Net earnings margin for the current
year was 10.4% compared to 11.1% and
10.1% in 1997 and 1996, respectively,
reflecting initiative investments.
Prior to January 1, 1998, both Brazil
and Peru were highly inflationary
economies, and accordingly, the results of
the Company’s subsidiaries in Brazil and
Peru were measured using the United
States dollar as their functional currency.
Effective January 1, 1998, neither Brazil
nor Peru qualified as a highly inflationary
economy. The impact of this change was
not material.
Hedging and Derivative Financial Instruments
The Company is exposed to market risk, including
changes in interest rates, currency exchange rates and
commodity prices. To manage the volatility relating
to these exposures on a consolidated basis, the
Company nets the exposures to take advantage of
natural offsets and enters into various derivative trans-
actions for the remaining exposures pursuant to the
Company’s policies in areas such as counterparty
exposure and hedging practices. The financial
impacts of these hedging instruments are offset by
corresponding changes in the underlying exposures
being hedged. The Company does not hold or issue
derivative financial instruments for trading purposes.
Note 5 to the consolidated financial statements
includes a discussion of the Company’s accounting
policies for financial instruments.
Derivative positions are monitored using techniques
including market value, sensitivity analysis and a value at
risk model. The tests for interest rate and currency rate
exposures discussed below are based on a variance/
co-variance value at risk model using a one-year hori-
zon and a 95% confidence level. The model assumes
that financial returns are normally distributed and
approximates the financial return for options and other
non-linear instruments. The model also reflects the
impact of correlation and diversification from holding
multiple currency and interest rate instruments.
Estimates of volatility and correlations of market factors
are drawn from the JP Morgan RiskMetrics™ dataset
as of June 30, 1998. In cases where data is unavailable in
RiskMetrics™, a reasonable approximation is included.
The effect of these estimates did not significantly
change the total value at risk.
The Company’s market risk exposures relative to
interest and currency rates, as discussed below, have
not changed materially versus the previous reporting
period. In addition, the Company is not aware of any
facts or circumstances that would significantly impact
such exposures in the near-term.
Latin America 
Net Sales
(Billions of Dollars)
Latin America 
Net Earnings
(Millions of Dollars)
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Interest Rate Exposure
Interest rate swaps are used to hedge underlying debt
obligations. Certain currency interest rate swaps are
designated to hedge the foreign currency exposure of
the Company’s related foreign net investments.
Based on the Company’s overall interest rate 
exposure as of and during the year ended June 30,
1998, including derivative and other interest rate
sensitive instruments, a near-term change in interest
rates, within a 95% confidence level based on histor-
ical interest rate movements, would not materially
affect the consolidated financial position, results of
operations or cash flows.
Currency Rate Exposures
The Company manufactures and sells its products in
a number of countries throughout the world and, as
a result, is exposed to movements in foreign currency
exchange rates. The major foreign currency exposures
involve the markets in Western Europe, Mexico and
Canada. The primary purpose of the Company’s
foreign currency hedging activities is to protect
against the volatility associated with foreign currency
purchases of materials and other assets and liabilities
created in the normal course of business. Corporate
policy prescribes the range of allowable hedging
activity. The Company primarily utilizes forward
exchange contracts and purchased options with
durations of generally less than 12 months.
In addition, the Company enters into foreign
currency swaps to hedge intercompany financing
transactions, and utilizes purchased foreign currency
options with durations of generally less than
18 months and forward exchange contracts to hedge
against the effect of exchange rate fluctuations on
royalties and foreign source income.
Based on the Company’s overall currency rate
exposure as of and during the year ended June 30,
1998, including derivative and other foreign currency
sensitive instruments, a near-term change in currency
rates, within a 95% confidence level based on histor-
ical currency rate movements, would not materially
affect the consolidated financial position, results of
operations or cash flows.
Commodity Price Exposure
Raw materials used by the Company are subject to
price volatility caused by weather, supply conditions
and other unpredictable factors. The Company uses
futures and options contracts, primarily in food and
beverage products, to manage the volatility related to
certain of these exposures. Gains and losses relating to
qualifying hedges of firm commitments or anticipated
inventory transactions are deferred in prepaid 
expenses and are included in the basis of the under-
lying transactions. Commodity hedging activity is not
material to the Company’s consolidated financial
position, results of operations or cash flows.
Organization 2005
The Company is currently designing Organization
2005, a realignment of the organization structure,
work processes and culture to accelerate growth and
innovation. While the details are not final, the design
will likely include:
• A move from current geographic business units
to product-based Global Business Units (GBUs).
• The further strengthening of country-based organ-
izations to provide even greater focus on deep local
level consumer and customer knowledge.
• The establishment of centers of excellence for key
administrative, logistics and support functions.
• Changes in the culture and reward systems to
encourage greater speed, innovation and flexibility.
The nature, timing and implications related to 
this design change have not yet been determined.
The Company expects to finalize plans and to make
available further details of the Organization 2005
changes in Fall 1998.
Year 2000
The Company has developed plans to address the
possible exposures related to the impact on its
computer systems of the Year 2000. Key financial,
information and operational systems, including equip-
ment with embedded microprocessors, have been
inventoried and assessed, and detailed plans are in place
for the required systems modifications or replacements. 
1972: First effective dryer-added fabric softener
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Progress against these plans is monitored and reported
to management and to the Audit Committee of the
Board of Directors on a regular basis. Implementation
of required changes to critical systems is expected to be
completed during fiscal 1999. Testing and certification
of critical systems, which includes review of docu-
mented remediation work and test results by technical
experts, key users and a central project team, is
expected to be successfully completed by December 31,
1999. In addition, the Company’s Internal Controls
organization plans to review the testing and certification
process and observe the testing of selected critical
systems in each region.
Critical Systems Description
% of Applications Year  Compliant
Actual as of Planned Planned
June  December  June 
Critical manufacturing, 
operating and 
control systems 44% 90% 100%
All other critical systems 56% 100% 100%
Incremental costs, which include contractor costs 
to modify existing systems and costs of internal
resources dedicated to achieving Year 2000 compliance,
are charged to expense as incurred. Costs are expected
to total approximately $100 million, of which 34% has
been spent to date.
The Company is also in contact with suppliers and
customers to assess the potential impact on operations if
key third parties are not successful in converting their
systems in a timely manner. Risk assessment, readiness
evaluation, action plans and contingency plans related
to these third parties are expected to be completed by
December 1998.
The Company’s risk management program
includes emergency backup and recovery procedures
to be followed in the event of failure of a business-
critical system. These procedures will be expanded to
include specific procedures for potential Year 2000
issues. Contingency plans to protect the business from
Year 2000-related interruptions are being developed.
These plans will be complete by June 1999 and will 
include, for example, development of backup proce-
dures, identification of alternate suppliers and possible
increases in safety inventory levels.
The Company is taking reasonable steps to
prevent major interruptions in the business due to
Year 2000 issues. The effect, if any, on the Company’s
results of operations if the Company, its customers or
its suppliers are not fully Year 2000 compliant is not
reasonably estimable. The Company believes its global
presence and broad-based manufacturing capability
help mitigate the risk.
Forward-Looking Statement
The Company has made and will make certain
forward-looking statements in the Annual Report and
in other contexts relating to volume growth, increases
in market shares, Year 2000 compliance, financial goals
and cost reduction, among others.
These forward-looking statements represent chal-
lenging goals for the Company and are based on certain
assumptions and estimates regarding the worldwide
economy, technological innovation, competitive activ-
ity, pricing, currency movements, product introduc-
tions, governmental action and the development of
certain markets. Among the key factors necessary to
achieve the Company’s goals are: (1) the achievement of
lower costs and increases in reliability and capacity
utilization, resulting from simplification and standard-
ization; (2) the ability to improve results despite high
levels of competitive activity and the economic down-
turn in Asia; (3) the successful implementation of ECR
and the ability to maintain key customer relationships 
in important developed markets; (4) the continuation of
substantial growth in significant developing markets
such as China, Mexico, Brazil and the countries 
of Central and Eastern Europe; (5) obtaining success-
ful outcomes in regulatory, tax and legal matters; 
(6) the ability to continue technological innovation; 
and (7) the timely resolution of the Year 2000 issue by
the Company and its customers and suppliers. If the
Company’s assumptions and estimates are incorrect or
do not come to fruition, or if the Company does not
achieve all of these key factors, then the Company’s
actual performance could vary materially from the
forward-looking statements made herein.
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Consolidated financial statements and financial information included in this report are the responsibility of
Company management. This includes preparing the statements in accordance with generally accepted accounting
principles and necessarily includes estimates based on management’s best judgments.
To help insure the accuracy and integrity of Company financial data, management maintains internal
controls designed to provide reasonable assurance that transactions are executed as authorized and accurately
recorded and that assets are properly safeguarded. These controls are monitored by an ongoing program of internal
audits. These audits are supplemented by a self-assessment program that enables individual organizations to evaluate
the effectiveness of their controls. Careful selection of employees and appropriate divisions of responsibility are
designed to achieve control objectives. The Company’s “Worldwide Business Conduct Manual” sets forth
management’s commitment to conduct its business affairs with the highest ethical standards.
Deloitte & Touche LLP, independent public accountants, have audited and reported on the Company’s consol-
idated financial statements. Their audits were performed in accordance with generally accepted auditing standards.
The Board of Directors, acting through its Audit Committee composed entirely of outside directors, oversees the
adequacy of internal controls. The Audit Committee meets periodically with representatives of Deloitte & Touche LLP
and internal financial management to review internal control, auditing and financial reporting matters. The indepen-
dent auditors and the internal auditors also have full and free access to meet privately with the Audit Committee.
John E. Pepper Erik G. Nelson
Chairman and Chief Executive Chief Financial Officer
R E P O R T O F  I N D E P E N D E N T A C C O U N T A N T S
250 East Fifth Street
Cincinnati, Ohio 45202
To the Board of Directors and Shareholders of The Procter & Gamble Company:
We have audited the accompanying consolidated balance sheets of The Procter & Gamble Company and
subsidiaries as of June 30, 1998 and 1997 and the related consolidated statements of earnings, shareholders’ equity,
and cash flows for each of the three years in the period ended June 30, 1998. These financial statements are the
responsibility of the Company’s management. Our responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require
that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free
of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial statement presentation. We believe that
our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the financial
position of the Company at June 30, 1998 and 1997 and the results of its operations and cash flows for each of the
three years in the period ended June 30, 1998, in conformity with generally accepted accounting principles.
July 30, 1998
1972: First dishwashing liquid with grease-cutting superiority
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C O N S O L I D A T E D  S T A T E M E N T S  O F  E A R N I N G S
Years Ended June 30
Amounts in Millions Except Per Share Amounts   
Net Sales $37,154 $35,764 $35,284
Cost of products sold 21,064 20,510 20,938
Marketing, research and administrative expenses 10,035 9,766 9,531
Operating Income 6,055 5,488 4,815
Interest expense 548 457 484
Other income, net 201 218 338
Earnings Before Income Taxes 5,708 5,249 4,669
Income taxes 1,928 1,834 1,623
Net Earnings $ 3,780 $ 3,415 $ 3,046
Basic Net Earnings Per Common Share $ 2.74 $ 2.43 $ 2.14
Diluted Net Earnings Per Common Share $ 2.56 $ 2.28 $ 2.01
Dividends Per Common Share $ 1.01 $ .90 $ .80
See accompanying Notes to Consolidated Financial Statements.
1975: First contour-shaped diaper
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C O N S O L I D A T E D  B A L A N C E  S H E E T S
June 30
Amounts in Millions Except Per Share Amounts  
ASSETS
Current Assets
Cash and cash equivalents $ 1,549 $ 2,350
Investment securities 857 760
Accounts receivable 2,781 2,738
Inventories
Materials and supplies 1,225 1,131
Work in process 343 228
Finished goods 1,716 1,728
Deferred income taxes 595 661
Prepaid expenses and other current assets 1,511 1,190
Total Current Assets 10,577 10,786
Property, Plant and Equipment
Buildings 3,660 3,409
Machinery and equipment 15,953 14,646
Land 539 570
20,152 18,625
Accumulated depreciation (7,972) (7,249)
Total Property, Plant and Equipment 12,180 11,376
Goodwill and Other Intangible Assets
Goodwill 7,023 3,915
Trademarks and other intangible assets 1,157 1,085
8,180 5,000
Accumulated amortization (1,169) (1,051)
Total Goodwill and Other Intangible Assets 7,011 3,949
Other Non-Current Assets 1,198 1,433
Total Assets $30,966 $27,544
See accompanying Notes to Consolidated Financial Statements.
1978: Didronel, the first global osteoporosis drug
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June 30
Amounts in Millions Except Per Share Amounts  
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable $ 2,051 $ 2,203
Accrued and other liabilities 3,942 3,802
Taxes payable 976 944
Debt due within one year 2,281 849
Total Current Liabilities 9,250 7,798
Long-Term Debt 5,765 4,143
Deferred Income Taxes 428 559
Other Non-Current Liabilities 3,287 2,998
Total Liabilities 18,730 15,498
Shareholders’ Equity
Convertible Class A preferred stock, 
stated value $1 per share 
(600 shares authorized) 1,821 1,859
Non-Voting Class B preferred stock, 
stated value $1 per share (200 shares 
authorized; none issued) – –
Common stock, stated value $1 per share 
(5,000 shares authorized; shares outstanding: 
1998–1,337.4 and 1997–1,350.8) 1,337 1,351
Additional paid-in capital 907 559
Reserve for employee stock ownership plan debt retirement (1,616) (1,634)
Accumulated other comprehensive income (1,357) (819)
Retained earnings 11,144 10,730
Total Shareholders’ Equity 12,236 12,046
Total Liabilities and Shareholders’ Equity $30,966 $27,544
1985: Superior paper-making technology yields stronger, more absorbent paper towels
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C O N S O L I D A T E D  S T A T E M E N T S  O F  S H A R E H O L D E R S ’ E Q U I T Y
Accumulated
Dollars in Common Additional Reserve for Other Total
Millions/Shares Shares Common Preferred Paid-in ESOP Debt Comprehensive Retained Comprehensive
in Thousands Outstanding Stock Stock Capital Retirement Income Earnings Total Income
Balance June 30, 1995 1,373,148 $1,373 $1,913 $129 $(1,734) $ 65 $ 8,843 $10,589
Net earnings 3,046 3,046 $3,046
Other comprehensive income:
Currency translation, 
net of $80 tax (483) (483) (483)
Other, net of tax 1 1 1
Reclassifications to 
net earnings (1) (1) (1)
Total comprehensive income $2,563
Dividends to shareholders:
Common (1,099) (1,099)
Preferred, net of tax benefit (103) (103)
Treasury purchases (10,468) (10) (422) (432)
Employee plan issuances 6,514 6 140 146
Preferred stock conversions 1,952 2 (27) 25 0
ESOP debt guarantee reduction 58 58
Balance June 30, 1996 1,371,146 1,371 1,886 294 (1,676) (418) 10,265 11,722
Net earnings 3,415 3,415 $3,415
Other comprehensive income:
Currency translation, 
net of $38 tax (416) (416) (416)
Other, net of tax 13 13 13
Reclassifications to 
net earnings 2 2 2
Total comprehensive income $3,014
Dividends to shareholders:
Common (1,225) (1,225)
Preferred, net of tax benefit (104) (104)
Treasury purchases (30,875) (31) (1,621) (1,652)
Employee plan issuances 8,801 9 240 249
Preferred stock conversions 1,771 2 (27) 25 0
ESOP debt guarantee reduction 42 42
Balance June 30, 1997 1,350,843 1,351 1,859 559 (1,634) (819) 10,730 12,046
Net earnings 3,780 3,780 $3,780
Other comprehensive income:
Currency translation, 
net of $25 tax (537) (537) (537)
Other, net of tax (1) (1) (1)
Total comprehensive income $3,242
Dividends to shareholders:
Common (1,358) (1,358)
Preferred, net of tax benefit (104) (104)
Treasury purchases (24,716) (25) (1,904) (1,929)
Employee plan issuances 8,777 9 312 321
Preferred stock conversions 2,557 2 (38) 36 0
ESOP debt guarantee reduction 18 18
Balance June 30, 1998 1,337,461 $1,337 $1,821 $907 $(1,616) $(1,357) $11,144 $12,236
See accompanying Notes to Consolidated Financial Statements.
1986: Super-absorbent polymer technology provides unparalleled dryness in a thin diaper
The Procter & Gamble Company and Subsidiaries
23
C O N S O L I D A T E D  S T A T E M E N T S  O F  C A S H  F L O W S
Years Ended June 30
Amounts in Millions   
Cash and Cash Equivalents, Beginning of Year $ 2,350 $ 2,074 $ 2,028
Operating Activities
Net earnings 3,780 3,415 3,046
Depreciation and amortization 1,598 1,487 1,358
Deferred income taxes (101) (26) 328
Change in accounts receivable 42 8 17
Change in inventories (229) (71) 202
Change in accounts payable, accrued and other liabilities (3) 561 (948)
Change in other operating assets and liabilities (65) 503 (134)
Other (137) 5 289
Total Operating Activities 4,885 5,882 4,158
Investing Activities
Capital expenditures (2,559) (2,129) (2,179)
Proceeds from asset sales 555 520 402
Acquisitions (3,269) (150) (358)
Change in investment securities 63 (309) (331)
Total Investing Activities (5,210) (2,068) (2,466)
Financing Activities
Dividends to shareholders (1,462) (1,329) (1,202)
Change in short-term debt 1,315 (160) 242
Additions to long-term debt 1,970 224 339
Reductions of long-term debt (432) (724) (619)
Proceeds from stock options 158 134 89
Treasury purchases (1,929) (1,652) (432)
Total Financing Activities (380) (3,507) (1,583)
Effect of Exchange Rate Changes 
on Cash and Cash Equivalents (96) (31) (63)
Change in Cash and Cash Equivalents (801) 276 46
Cash and Cash Equivalents, End of Year $ 1,549 $ 2,350 $ 2,074
Supplemental Disclosure
Cash payments for:
Interest, net of amount capitalized $ 536 $ 449 $ 459
Income taxes 2,056 1,380 1,339
Liabilities assumed in acquisitions 808 42 56
See accompanying Notes to Consolidated Financial Statements.
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1 Summary of Significant Accounting Policies
Basis of Presentation: The consolidated financial state-
ments include The Procter & Gamble Company and its
controlled subsidiaries (the Company). Investments in
companies that are at least 20% to 50% owned, and over
which the Company exerts significant influence but
does not control the financial and operating decisions,
are accounted for by the equity method. These invest-
ments are managed as integral parts of the Company’s
segment operations, and the Company’s share of their
results is included in net sales for the related segments.
Use of Estimates: Preparation of financial statements in
conformity with generally accepted accounting princi-
ples requires management to make estimates and
assumptions that affect the amounts reported in the
consolidated financial statements and accompanying
disclosures. These estimates are based on management’s
best knowledge of current events and actions the
Company may undertake in the future. Actual results
may ultimately differ from estimates.
Accounting Changes: In 1998, the Company adopted
several FASB statements. Statement No. 128,
“Earnings per Share,” which revises the manner in
which earnings per share is calculated, did not impact
the Company’s previously reported earnings per share.
Statement No. 130, “Reporting Comprehensive
Income,” requires the components of comprehensive
income to be disclosed in the financial statements.
Statement No. 131, “Disclosures about Segments of
an Enterprise and Related Information,” requires
certain information to be reported about operating
segments on a basis consistent with the Company’s
internal organizational structure. Statement No. 132,
“Employers’ Disclosures about Pensions and Other
Postretirement Benefits,” revises the disclosures for
pensions and other postretirement benefits and
standardizes them into a combined format. Required
disclosures have been made and prior years’ informa-
tion has been reclassified for the impact of FASB
Statements 130, 131 and 132.
New Pronouncements: In June 1998, the FASB issued
Statement No. 133, “Accounting for Derivative
Instruments and Hedging Activities,” which revises the
accounting for derivative financial instruments. 
In March 1998, the AICPA issued SOP 98-1, 
“Accounting for the Costs of Computer Software 
Developed or Obtained for Internal Use,” which revises
the accounting for software development costs 
and will require the capitalization of certain costs 
which the Company has historically expensed. The
Company is currently analyzing the impacts of these
statements, which are required to be adopted in 2000,
and does not expect either statement to have a material
impact on the Company’s financial position, results of
operations or cash flows.
Currency Translation: Financial statements of subsidiaries
outside the U.S. generally are measured using the local
currency as the functional currency. Adjustments to
translate those statements into U.S. dollars are accumu-
lated in a separate component of shareholders’ equity.
For subsidiaries operating in highly inflationary
economies, the U.S. dollar is the functional currency.
Remeasurement adjustments for highly inflationary
economies and other transactional exchange gains
(losses) are reflected in earnings and were $0, $1 and
$(28) for 1998, 1997 and 1996, respectively.
Cash Equivalents: Highly liquid investments with
maturities of three months or less when purchased are
considered cash equivalents.
Inventory Valuation: Inventories are valued at cost,
which is not in excess of current market price. Cost is
primarily determined by either the average cost or
the first-in, first-out method. The replacement cost of
last-in, first-out inventories exceeds carrying value by
approximately $91 and $122 at June 30, 1998 and
1997, respectively.
Goodwill and Other Intangible Assets: The cost of
intangible assets is amortized, principally on a
straight-line basis, over the estimated periods bene-
fited, generally 40 years for goodwill and periods
ranging from 10 to 40 years for other intangible assets.
The realizability of goodwill and other intangibles is
evaluated periodically when events or circumstances
indicate a possible inability to recover the carrying
amount. Such evaluation is based on various analyses,
including cash flow and profitability projections that
incorporate the impact of existing Company busi-
nesses. The analyses necessarily involve significant
management judgment to evaluate the capacity of an
acquired business to perform within projections.
Historically, the Company has generated sufficient
returns from acquired businesses to recover the cost of
the goodwill and other intangible assets.
1986: First complete shampoo and conditioner in one
1986: Patented “Wings” technology combined with “Dri-Weave” topsheet creates superior feminine protection
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Property, Plant and Equipment: Property, plant and equip-
ment are recorded at cost reduced by accumulated
depreciation. Depreciation expense is provided based on
estimated useful lives using the straight-line method.
Selected Operating Expenses: Research and development
costs are charged to earnings as incurred and were $1,546
in 1998, $1,469 in 1997 and $1,399 in 1996. Advertising
costs are charged to earnings as incurred and were $3,704
in 1998, $3,466 in 1997 and $3,254 in 1996.
Net Earnings Per Common Share: Net earnings less
preferred dividends (net of related tax benefits) are
divided by the weighted average number of common
shares outstanding during the year to calculate basic net
earnings per common share. Diluted net earnings per
common share are calculated to give effect to stock
options and convertible preferred stock.
Basic and diluted net earnings per share are recon-
ciled as follows:
Years Ended June 30
  
Net earnings available to 
common shareholders $3,676 $3,311 $2,943
Effect of dilutive securities
Preferred dividends, 
net of tax benefit 104 104 103
Preferred dividend 
impact on funding 
of ESOP (25) (32) (39)
Diluted net earnings 3,755 3,383 3,007
Basic weighted average 
common shares 
outstanding 1,343.4 1,360.3 1,372.6
Effect of dilutive securities
Conversion of 
preferred shares 99.8 101.9 103.8
Exercise of stock options 22.3 24.8 19.8
Diluted weighted average 
common shares 
outstanding 1,465.5 1,487.0 1,496.2
Stock Split: In July 1997, the Company’s board of
directors approved a two-for-one stock split that was
effective for common and preferred shareholders of
record as of August 22, 1997. The financial statements,
notes and other references to share and per-share data
reflect the stock split for all periods presented.
Fair Values of Financial Instruments: Fair values of cash
equivalents, short and long-term investments and short-
term debt approximate cost. The estimated fair values of 
other financial instruments, including debt and risk
management instruments, have been determined using
available market information and valuation method-
ologies, primarily discounted cash flow analysis. These 
estimates require considerable judgment in interpreting
market data, and changes in assumptions or estimation
methods may significantly affect the fair value estimates.
Major Customer: The Company’s largest customer, 
Wal-Mart Stores, Inc. and its affiliates, accounted for 
11% and 10% of consolidated net sales in 1998 and
1997, respectively. These sales occurred primarily in
the North America segment.
Reclassifications: Certain reclassifications of prior years’
amounts have been made to conform with the current
year presentation, primarily related to certain compo-
nent parts of research and development costs.
2 Acquisitions
In July 1997, the Company acquired Tambrands, Inc., a
company in the feminine protection category, for
approximately $1,844 in cash. Other acquisitions in 1998
totaled $1,425 and included the acquisition of paper
businesses and increased ownership in various ventures
in Latin America and Asia. These acquisitions, all of
which were accounted for using the purchase method,
resulted in goodwill of $3,335. Acquisitions accounted
for as purchases in 1997 and 1996 totaled $150 and $358,
respectively.
The following table reflects unaudited pro forma
combined results of operations on the basis that the
1998 acquisitions had taken place at the beginning of
the year for each of the periods presented:
Years Ended June 30
 
Pro forma amounts
Net sales $37,476 $37,008
Net earnings 3,756 3,409
Net earnings per common share
Basic 2.72 2.43
Diluted 2.55 2.27
In management’s opinion, the unaudited pro forma
combined results of operations are not indicative of 
the actual results that would have occurred under the
ownership and management of the Company.
1989: First North American laundry detergent with activated bleach26
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3 Supplemental Balance Sheet Information
June 30
 
Accrued and Other Liabilities
Marketing expenses $1,109 $1,129
Compensation expenses 485 461
Other 2,348 2,212
3,942 3,802
Other Non-Current Liabilities
Postretirement benefits $1,193 $1,300
Pension benefits 843 815
Other 1,251 883
3,287 2,998
Currency
Translation Other Total
Accumulated Other
Comprehensive Income
Balance June 30, 1995 $ 64 $ 1 $ 65
Current period change (483) 0 (483)
Balance June 30, 1996 (419) 1 (418)
Current period change (412) 11 (401)
Balance June 30, 1997 (831) 12 (819)
Current period change (536) (2) (538)
Balance June 30, 1998 (1,367) 10 (1,357)
4 Short-Term and Long-Term Debt
June 30
 
Short-Term Debt
U.S. obligations $1,435 $183
Foreign obligations 560 343
Current portion of long-term debt 286 323
2,281 849
The weighted average short-term interest rates 
were 6.2% and 6.9% as of June 30, 1998 and 1997,
respectively.
Average June 30
Rate Maturities  
Long-Term Debt
U.S. notes and 
debentures 6.96% 1998-2029 $2,897 $2,082
ESOP Series A 8.33% 1998-2004 545 613
ESOP Series B 9.36% 2021 1,000 1,000
U.S. commercial 
paper 1,207 585
Foreign obligations 402 186
Current portion of 
long-term debt (286) (323)
5,765 4,143
Long-term weighted average interest rates in the
preceding table are as of June 30, 1998 and include
the effects of related interest rate swaps discussed in
Note 5. Certain commercial paper balances have
been classified as long-term debt based on the
Company’s intent and ability to renew the obligations
on a long-term basis. The Company has entered into
derivatives that convert certain of these commercial
paper obligations into fixed-rate obligations.
The fair value of the long-term debt was $6,412 and
$4,509 at June 30, 1998 and 1997, respectively. Long-
term debt maturities during the next five years are as
follows: 1999 – $286; 2000 – $387; 2001– $339;
2002 – $427 and 2003 – $1,141.
5 Risk Management Activities
The Company is exposed to market risk, including
changes in interest rates, currency exchange rates and
commodity prices. To manage the volatility relating to
these exposures on a consolidated basis, the Company 
nets the exposures to take advantage of natural offsets
and enters into various derivative transactions for the
remaining exposures pursuant to the Company’s poli-
cies in areas such as counterparty exposure and hedging
practices. The financial impacts of these hedging instru-
ments are offset by corresponding changes in the
underlying exposures being hedged. The Company
does not hold or issue derivative financial instruments
for trading purposes.
Interest Rate Management
The Company’s policy is to manage interest cost using
a mix of fixed and variable rate debt. To manage this
mix in a cost-efficient manner, the Company enters
into interest rate swaps, in which the Company agrees
to exchange, at specified intervals, the difference
between fixed and variable interest amounts calculated
by reference to an agreed-upon notional principal
amount. These swaps are designated to hedge underly-
ing debt obligations. For qualifying hedges, the interest
rate differential is reflected as an adjustment to interest
expense over the life of the swaps.
Certain currency interest rate swaps are designated
to hedge the foreign currency exposure of the
Company’s related foreign net investments. Currency
effects of these hedges are reflected in the accumu-
lated other comprehensive income section of share-
holders’ equity, offsetting a portion of the translation
of the net assets.
1990: Breakthrough technology in a non-chlorine, gentle bleach
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The following table presents information for all
interest rate instruments. The notional amount does not
necessarily represent amounts exchanged by the parties
and, therefore, is not a direct measure of the Company’s
exposure to credit risk. The fair value approximates the
cost to settle the outstanding contracts. The carrying
value includes the net amount due to counterparties
under swap contracts, currency translation associated
with currency interest rate swaps and any marked-to-
market value adjustments of instruments.
June 30
 
Notional amount $2,149 $1,488
Fair value $ 7 $ (54)
Carrying value 28 (28)
Unrecognized loss (21) (26)
Although derivatives are an important component
of the Company’s interest rate management program,
their incremental effect on interest expense for 1998,
1997 and 1996 was not material.
Currency Rate Management
The Company manufactures and sells its products in
a number of countries throughout the world and, as
a result, is exposed to movements in foreign currency
exchange rates. The major foreign currency exposures
involve the markets in Western Europe, Mexico and
Canada. The primary purpose of the Company’s
foreign currency hedging activities is to protect
against the volatility associated with foreign currency
purchases of materials and other assets and liabilities
created in the normal course of business. Corporate
policy prescribes the range of allowable hedging
activity. The Company primarily utilizes forward
exchange contracts and purchased options with dura-
tions of generally less than 12 months.
In addition, the Company enters into foreign
currency swaps to hedge intercompany financing trans-
actions, and utilizes purchased foreign currency options
with durations of generally less than 18 months and
forward exchange contracts to hedge against the effect of
exchange rate fluctuations on royalties and foreign
source income.
Gains and losses related to qualifying hedges of
foreign currency firm commitments or anticipated
transactions are deferred in prepaid expense and are
included in the basis of the underlying transactions.
To the extent that a qualifying hedge is terminated or
ceases to be effective as a hedge, any deferred gains
and losses up to that point continue to be deferred
and are included in the basis of the underlying trans-
action. All other foreign exchange contracts are
marked-to-market on a current basis, generally to
marketing, research and administration expense. To
the extent anticipated transactions are no longer likely
to occur, the related hedges are closed with gains or
losses charged to earnings on a current basis.
Currency instruments outstanding are as follows:
June 30
 
Notional amount
Forward contracts $3,448 $2,607
Purchased options 1,262 1,643
Currency swaps 217 358
Fair value
Forward contracts $ 30 $ (2)
Purchased options 16 38
Currency swaps 8 (1)
The deferred gains and losses on these instruments
were not material.
In addition, in order to hedge currency exposures
related to the net investments in foreign subsidiaries,
the Company utilizes local currency financing
entered into by the subsidiaries, and currency interest
rate swaps and other foreign currency denominated
financing instruments entered into by the parent.
Gains and losses on instruments designated as hedges
of net investments are offset against the translation
effects reflected in shareholders’ equity.
Currency interest rate swaps, foreign currency
instruments and foreign currency denominated debt
that have been designated as hedges of the Company’s
net investment exposure in certain foreign subsidiaries
have notional amounts totaling $1,138 and $936 at 
June 30, 1998 and 1997, respectively. These hedges
resulted in gains of $42 and $63, net of $25 and $38 in
tax effects, reflected in shareholders’ equity.
1990: First tartar control toothpaste28
The Procter & Gamble Company and SubsidiariesN O T E S  T O  C O N S O L I D A T E D  F I N A N C I A L S T A T E M E N T S  ( C O N T I N U E D )
Millions of Dollars Except Per Share Amounts
Credit Risk
Credit risk arising from the inability of a counterparty to
meet the terms of the Company’s financial instrument
contracts is generally limited to the amounts, if any, by
which the counterparty’s obligations exceed the obli-
gations of the Company. It is the Company’s policy to
enter into financial instruments with a diversity of
creditworthy counterparties. Therefore, the Company
does not expect to incur material credit losses on its risk
management or other financial instruments.
6 Stock Options
The Company has stock-based compensation plans
under which stock options are granted annually to key
managers and directors at the market price on the date
of grant. The grants are fully exercisable after one year
and have a ten-year life. In 1998, the Company granted
stock options to all eligible employees not covered by
the key manager and director plans. These grants,
which comprised 8.7 million of the 20.3 million
options granted in 1998, are fully exercisable after five
years and have a ten-year life. The Company issues
stock appreciation rights in countries where stock
options have not been approved by local governments.
Pursuant to FASB Statement No. 123, “Accounting
for Stock-Based Compensation,” the Company has
elected to account for its employee stock option plans
under APB Opinion No. 25, “Accounting for Stock
Issued to Employees.” Accordingly, no compensation
cost has been recognized for these plans. Had compen-
sation cost for the plans been determined based on the
fair value at the grant date consistent with FASB
Statement No. 123, the Company’s net earnings and
earnings per share would have been as follows:
Years Ended June 30
  
Net earnings
As reported $3,780 $3,415 $3,046
Pro forma 3,472 3,305 2,981
Net earnings per 
common share
Basic
As reported $ 2.74 $ 2.43 $ 2.14
Pro forma 2.51 2.35 2.10
Diluted
As reported 2.56 2.28 2.01
Pro forma 2.35 2.20 1.97
The fair value of each option grant is estimated on the
date of grant using the Binomial option-pricing model
with the following weighted average assumptions:
Years Ended June 30
  
Interest rate 5.6% 6.6% 6.1%
Dividend yield 2% 2% 2%
Expected volatility 26% 22% 20%
Expected life in years 6 6 6
Stock option activity was as follows:
Options in Thousands
  
Outstanding, July 1 68,514 66,657 63,384
Granted 20,315 10,409 9,605
Exercised (8,477) (8,357) (6,110)
Canceled (434) (195) (222)
Outstanding, June 30 79,918 68,514 66,657
Exercisable 59,610 58,098 57,048
Available for grant 31,558 28,538 24,418
Average price
Outstanding, 
beginning of year $31.00 $24.79 $21.36
Granted 83.26 58.72 40.87
Exercised 18.57 16.02 14.52
Outstanding, end of year 45.58 31.00 24.79
Exercisable, end of year 32.74 26.03 22.09
Weighted average grant 
date fair value of options 24.56 17.14 10.88
The following table summarizes information
about stock options outstanding at June 30, 1998:
Options Outstanding
Number Weighted-Avg
Range of Outstanding Weighted-Avg Remaining
Prices (Thousands) Exercise Price Contractual Life
$ 8 to 30 33,626 $22.69 3.4 years
33 to 46 16,821 37.85 7.1
57 to 71 9,349 60.42 8.5
71 to 85 20,122 83.39 9.5
1992: Breakthrough Carezyme technology prevents fuzzing and color fading
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The following table summarizes information
about stock options exercisable at June 30, 1998:
Options Exercisable
Number
Range of Exercisable Weighted-Avg
Prices (Thousands) Exercise Price
$ 8 to 30 33,626 $22.69
33 to 46 16,821 37.85
57 to 71 9,163 60.24
71 to 85 – –
7 Postretirement Benefits
The Company offers various postretirement benefits
to its employees.
Defined Contribution Retirement Plans
Within the U.S., the most significant retirement
benefit is the defined contribution profit sharing plan
funded by an employee stock ownership plan
(ESOP) and Company contributions. Annual credits
to participants’ accounts are based on individual base
salaries and years of service, and do not exceed 15%
of total participants’ annual salaries and wages.
Years Ended June 30
  
ESOP preferred shares 
allocated at market value $235 $247 $200
Company contributions 58 35 75
Benefits earned 293 282 275
Other Retiree Benefits
The Company also provides certain health care and
life insurance benefits for substantially all U.S.
employees who become eligible for these benefits
when they meet minimum age and service require-
ments. Generally, the health care plans require contri-
butions from retirees and pay a stated percentage of
expenses, reduced by deductibles and other coverages.
Retiree contributions change annually in line with
medical cost trends. These benefits are partially
funded by an ESOP, as well as certain other assets
contributed by the Company.
Certain other employees, primarily outside the
U.S., are covered by local defined benefit pension,
health care and life insurance plans.
Summarized information on the Company’s
postretirement plans is as follows:
Other
Pension Benefits Retiree Benefits
Years Ended June 30
   
Change in Benefit 
Obligation
Benefit obligation at 
beginning of year $1,991 $1,886 $ 1,460 $ 1,405
Service cost 106 100 42 45
Interest cost 148 131 102 109
Participants’ 
contributions 3 5 11 12
Amendments 21 2 (6) 5
Actuarial loss (gain) 87 54 (71) (50)
Acquisitions 154 42 1 0
Curtailments 13 0 0 0
Currency exchange (85) (117) (7) (4)
Benefit payments (156) (112) (67) (62)
Benefit obligation 
at end of year 2,282 1,991 1,465 1,460
Change in Plan 
Assets
Fair value of plan 
assets at beginning 
of year 1,229 1,019 1,828 838
Actual return on 
plan assets 243 180 803 999
Acquisitions 131 42 0 0
Employer 
contributions 103 83 37 41
Participants’ 
contributions 3 5 11 12
Currency exchange (30) 12 (1) 0
Benefit payments (156) (112) (67) (62)
Fair value of plan 
assets at end 
of year 1,523 1,229 2,611 1,828
Funded Status
Funded status at 
end of year (759) (762) 1,146 368
Unrecognized net 
actuarial gain (163) (95) (2,354) (1,691)
Unrecognized 
transition amount 32 35 0 0
Unrecognized prior 
service cost 75 43 (21) (17)
Net amount 
recognized (815) (779) (1,229) (1,340)
Prepaid benefit cost $ 34 $ 52 $ 1 $ 0
Accrued benefit cost (849) (831) (1,230) (1,340)
Net liability 
recognized (815) (779) (1,229) (1,340)
1992: First penetrating, pro-vitamin formula for hair with superior shine
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The Company’s stock comprised $2,443 and $1,687
of other retiree plan assets, net of Series B ESOP debt,
as of June 30, 1998 and 1997, respectively.
Other
Pension Benefits Retiree Benefits
Years Ended June 30
   
Weighted Average 
Assumptions
Discount rate 7.0% 7.2% 6.8% 7.5%
Expected return 
on plan assets 9% 9% 9% 9%
Rate of 
compensation 
increase 5% 5% – –
Initial health care 
cost trend rate* – – 8% 9%
*Assumed to decrease gradually to 5% in 2006 and remain at
that level thereafter.
Other
Pension Benefits Retiree Benefits
Years Ended June 30
     
Components of 
Net Periodic 
Benefit Cost
Service cost $ 106 $100 $ 96 $ 42 $ 45 $ 47
Interest cost 148 131 131 102 109 102
Expected return 
on plan assets (103) (87) (75) (171) (138) (121)
Amortization of 
prior service cost 7 5 6 (2) (2) (2)
Amortization of 
transition amount 3 0 0 0 0 0
Curtailment loss 12 0 0 0 0 0
Recognized net 
actuarial gain 0 (7) (3) (41) (18) (15)
Gross benefit cost 173 142 155 (70) (4) 11
Dividends on ESOP 
preferred stock 0 0 0 (78) (79) (79)
Net periodic 
benefit cost 173 142 155 (148) (83) (68)
The projected benefit obligation, accumulated
benefit obligation and fair value of plan assets for the
pension plans with accumulated benefit obligations in
excess of plan assets were $1,206, $984 and $155,
respectively, as of June 30, 1998, and $1,172, $899 and
$158, respectively, as of June 30, 1997.
Assumed health care cost trend rates have a signif-
icant effect on the amounts reported for the health
care plans. A one-percentage-point change in
assumed health care cost trend rates would have the
following effects:
1-Percentage- 1-Percentage-
Point Increase Point Decrease
Effect on total of service and 
interest cost components $ 26 $ (22)
Effect on postretirement 
benefit obligation 207 (181)
8 Employee Stock Ownership Plan
The Company maintains the Procter & Gamble
Profit Sharing Trust and Employee Stock Ownership
Plan (ESOP) to provide funding for two primary
postretirement benefits described in Note 7: a
defined contribution profit sharing plan and certain
U.S. postretirement health care benefits.
The ESOP borrowed $1,000 in 1989, which has
been guaranteed by the Company. The proceeds were
used to purchase Series A ESOP Convertible Class A
Preferred Stock to fund a portion of the defined
contribution plan. Principal and interest requirements
are $117 per year, paid by the trust from dividends on
the preferred shares and from cash contributions and
advances from the Company. The shares are convert-
ible at the option of the holder into one share of the
Company’s common stock. The liquidation value is
equal to the issue price of $13.75 per share.
In 1991, the ESOP borrowed an additional $1,000,
also guaranteed by the Company. The proceeds were
used to purchase Series B ESOP Convertible Class A
Preferred Stock to fund a portion of retiree health care
benefits. Debt service requirements are $94 per year,
funded by preferred stock dividends and cash contri-
butions from the Company. Each share is convertible at
the option of the holder into one share of the
Company’s common stock. The liquidation value is
equal to the issuance price of $26.12 per share.
Shares in Thousands
  
Shares Outstanding
Series A 60,635 62,952 64,562
Series B 37,805 38,045 38,204
1992: Asacol launched for treatment of ulcerative colitis
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Shares of the ESOP are allocated at original cost
based on debt service requirements, net of advances
made by the Company to the trust. The fair value of
the Series A shares serves to reduce the Company’s cash
contribution required to fund the profit sharing plan
contributions earned. The Series B shares are consid-
ered plan assets of the other retiree benefits plan.
Dividends on all preferred shares, net of related tax
benefit, are charged to retained earnings. The preferred
shares held by the ESOP are considered outstanding
from inception for purposes of calculating diluted net
earnings per common share.
9 Income Taxes
Earnings before income taxes consist of the following:
Years Ended June 30
  
United States $3,632 $3,232 $3,023
International 2,076 2,017 1,646
5,708 5,249 4,669
The income tax provision consists of the following:
Years Ended June 30
  
Current tax expense
U.S. Federal $ 996 $ 967 $ 776
International 918 805 413
U.S. State & Local 115 88 106
2,029 1,860 1,295
Deferred tax expense
U.S. Federal 51 1 220
International & other (152) (27) 108
(101) (26) 328
Total 1,928 1,834 1,623
Taxes credited to shareholders’ equity for the years
ended June 30, 1998 and 1997 were $147 and $97,
respectively. Undistributed earnings of foreign sub-
sidiaries that are considered to be reinvested indefinitely
were $6,739 at June 30, 1998.
The effective income tax rate was 33.8%, 34.9%
and 34.8% in 1998, 1997 and 1996, respectively,
compared to the U.S. statutory rate of 35%.
Deferred income tax assets and liabilities are
comprised of the following:
June 30
 
Current deferred tax assets $ 595 $ 661
Non-current deferred tax 
assets (liabilities)
Depreciation (1,058) (1,031)
Postretirement benefits 435 475
Loss carryforwards 167 84
Other 28 (87)
(428) (559)
Included in the above are total valuation
allowances of $177 and $113 in 1998 and 1997, respec-
tively. The valuation allowance increased in 1998
primarily due to the generation of additional net
operating loss carryforwards.
10 Commitments and Contingencies
The Company has purchase commitments for materi-
als, supplies, and property, plant and equipment inci-
dental to the ordinary conduct of business. In the
aggregate, such commitments are not at prices in excess
of current market.
The Company is subject to various lawsuits and
claims with respect to matters such as governmental
regulations, income taxes and other actions arising out
of the normal course of business. The Company is also
subject to contingencies pursuant to environmental
laws and regulations that in the future may require the
Company to take action to correct the effects on the
environment of prior manufacturing and waste
disposal practices. Accrued environmental liabilities for
remediation and closure costs at June 30, 1998 were
$66, and in management’s opinion, such accruals are
appropriate based on existing facts and circumstances.
Current year expenditures were not material.
While the effect on future results of these items is not
subject to reasonable estimation because considerable
uncertainty exists, in the opinion of management and
Company counsel, the ultimate liabilities resulting from
such claims will not materially affect the consolidated
financial position, results of operations or cash flows of
the Company.
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Europe,
North Middle East Latin
America and Africa Asia America Corporate Total
Net Sales  $18,456 $11,835 $3,453 $2,640 $ 770 $37,154
 17,625 11,587 3,573 2,306 673 35,764
 17,230 11,458 3,881 2,173 542 35,284
Net Earnings  2,474 1,092 174 274 (234) 3,780
 2,253 956 275 256 (325) 3,415
 1,953 793 273 219 (192) 3,046
Earnings Before Income Taxes  3,789 1,540 266 329 (216) 5,708
 3,516 1,446 400 326 (439) 5,249
 3,055 1,137 433 236 (192) 4,669
Identifiable Assets  11,063 5,998 2,499 1,519 9,887 30,966
 10,280 5,433 2,726 1,389 7,716 27,544
 10,382 5,853 2,770 1,270 7,455 27,730
Capital Expenditures  1,433 686 266 174 - 2,559
 1,163 547 287 132 - 2,129
 1,080 602 322 175 - 2,179
Depreciation and Amortization  755 374 174 97 198 1,598
 693 405 167 83 139 1,487
 633 380 143 48 154 1,358
Interest Expense  - - - - 548 548
 - - - - 457 457
 - - - - 484 484
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Millions of Dollars Except Per Share Amounts
11 Segment Information
The Company has adopted FASB Statement No. 131,
“Disclosures about Segments of a Business Enterprise
and Related Information.” The Company is managed
in four operating segments: North America, which
includes the United States and Canada; Europe, Middle
East and Africa; Asia; and Latin America.
Corporate operations include certain financing
and employee benefits costs, goodwill amortization, 
other general corporate income and expense,
segment eliminations and projects included in the
Company’s ongoing simplification and standardization
program, which includes costs for consolidation of
selected manufacturing facilities, re-engineering of
manufacturing and distribution processes, organiza-
tion redesign and simplified product line-ups, as well
as gains and losses on sales of non-strategic brands and
assets. Corporate assets include primarily cash,
investment securities and goodwill.
Product Net Sales Information
The following is supplemental information on net
sales by product groups, aligned as follows:
Laundry and Cleaning – dishcare, fabric condi-
tioners, hard surface cleaners and laundry.
Paper – diapers, feminine protection, inconti-
nence, tissue and towel, and wipes.
Beauty Care–cosmetics and fragrances, deodorants,
hair care, and skin care and personal cleansing.
Food and Beverage – coffee, commercial services,
juice, peanut butter, shortening and oil, and snacks.
Health Care – gastrointestinal, oral care, pharma-
ceuticals and respiratory care.
Laundry and Beauty Food and Health Corporate
Cleaning Paper Care Beverage Care & Other Total
 $11,099 $10,862 $7,160 $4,376 $2,849 $808 $37,154
 10,892 10,101 7,101 4,107 2,895 668 35,764
 10,683 10,161 6,916 4,066 2,939 519 35,284
1994: First body wash with puff that cleans and conditions your skin
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12 Quarterly Results (Unaudited)
Quarters Ended Total
Sept.  Dec.  Mar.  June  Year
Net Sales - $9,355 $9,641 $8,881 $9,277 $37,154
- 8,903 9,142 8,771 8,948 35,764
Operating Income - 1,739 1,688 1,516 1,112 6,055
- 1,547 1,521 1,383 1,037 5,488
Net Earnings - 1,087 1,046 961 686 3,780
- 979 944 881 611 3,415
Basic Net Earnings Per Common Share - .79 .76 .69 .50 2.74
- .70 .67 .63 .43 2.43
Diluted Net Earnings Per Common Share - .73 .71 .65 .47 2.56
- .65 .63 .59 .41 2.28
    
Net Sales 37,154 35,764 35,284 33,482 30,385
Operating Income 6,055 5,488 4,815 4,244 3,670
Net Earnings 3,780 3,415 3,046 2,645 2,211
Net Earnings Margin 10.2% 9.5% 8.6% 7.9% 7.3%
Basic Net Earnings Per Common Share 2.74 2.43 2.14 1.85 1.54
Diluted Net Earnings Per Common Share 2.56 2.28 2.01 1.74 1.45
Dividends Per Common Share 1.01 .90 .80 .70 .62
Research and Development Expense 1,546 1,469 1,399 1,304 1,162
Advertising Expense 3,704 3,466 3,254 3,284 2,996
Total Assets 30,966 27,544 27,730 28,125 25,535
Capital Expenditures 2,559 2,129 2,179 2,146 1,841
Long-Term Debt 5,765 4,143 4,670 5,161 4,980
Shareholders’ Equity 12,236 12,046 11,722 10,589 8,832
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Directors
Edwin L. Artzt Retired Chairman of the Board and Chief Executive
Norman R. Augustine Chairman of the Executive Committee, Lockheed Martin Corporation – aerospace,
electronics, information management, materials and energy systems and products
Donald R. Beall Retired Chairman and Chief Executive Officer, Rockwell International Corporation –
automation, avionics and communications and semiconductor systems – and 
Chairman of the Executive Committee, Rockwell International Corporation
Gordon F. Brunner Senior Vice President
Richard B. Cheney Chairman of the Board and Chief Executive Officer, Halliburton Company –
energy services, engineering and construction
Harald Einsmann Executive Vice President
Richard J. Ferris Retired Co-Chairman, Doubletree Corporation
Joseph T. Gorman Chairman and Chief Executive Officer, TRW Inc. – automotive, space, defense 
and information systems
Durk I. Jager President and Chief Operating Officer
Charles R. Lee Chairman and Chief Executive Officer, GTE Corporation – telecommunication services
Lynn M. Martin Professor, Davee Chair, J. L. Kellogg Graduate School of Management, 
Northwestern University
John E. Pepper Chairman of the Board and Chief Executive
John C. Sawhill President and Chief Executive Officer, The Nature Conservancy – an international
conservation organization
John F. Smith, Jr. Chairman, Chief Executive Officer and President, General Motors Corporation –
automobile and related businesses
Ralph Snyderman Chancellor for Health Affairs, Dean, School of Medicine at Duke University, 
and President/CEO of Duke University Health System
Robert D. Storey Partner in the law firm of Thompson, Hine & Flory P.L.L.
Marina v.N. Whitman Professor of Business Administration and Public Policy, University of Michigan
Board Committees
Executive Committee
E. L. Artzt, Chairman
J. E. Pepper
N. R. Augustine
D. R. Beall
R. J. Ferris
J. T. Gorman
Audit Committee
D. R. Beall, Chairman
R. B. Cheney
C. R. Lee
J. C. Sawhill
J. F. Smith, Jr.
R. Snyderman
R. D. Storey
Compensation Committee
N. R. Augustine, Chairman
D. R. Beall
R. B. Cheney
J. T. Gorman
M. v.N. Whitman
Finance Committee
R. J. Ferris, Chairman
E. L. Artzt
N. R. Augustine
J. T. Gorman
L. M. Martin
M. v.N. Whitman
Board Organization and 
Nominating Committee
M. v.N. Whitman, Chairman
R. J. Ferris
C. R. Lee
L. M. Martin
J. C. Sawhill
J. F. Smith, Jr.
R. Snyderman
R. D. Storey
Public Policy Committee
R. D. Storey, Chairman
E. L. Artzt
R. B. Cheney
C. R. Lee
L. M. Martin
J. C. Sawhill
J. F. Smith, Jr.
R. Snyderman
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Corporate Officers
John E. Pepper Chairman of the Board and Chief Executive
Durk I. Jager President and Chief Operating Officer
Wolfgang C. Berndt Executive Vice President (President – North America)
Harald Einsmann Executive Vice President (President – Europe, Middle East and Africa)
Alan G. Lafley Executive Vice President (President – Asia)
Jorge P. Montoya Executive Vice President (President – Latin America)
Richard L. Antoine Senior Vice President (Human Resources)
Gordon F. Brunner Senior Vice President (Research and Development)
Stephen N. David Senior Vice President (Customer Business Development)
Todd A. Garrett Senior Vice President (Chief Information Officer)
James J. Johnson Senior Vice President and General Counsel
Gary T. Martin Senior Vice President (Product Supply)
Erik G. Nelson Senior Vice President (Chief Financial Officer)
Charlotte R. Otto Senior Vice President (Public Affairs)
Robert L. Wehling Senior Vice President (Advertising, Market Research and Government Relations)
Robert T. Blanchard Group Vice President (President, Beauty Care Products – North America, 
Procter & Gamble North America)
Brian J. Buchan Group Vice President (President, Paper Products – Asia)
Bruce L. Byrnes Group Vice President (President, Health Care Products – North America, 
Procter & Gamble North America)
R. Kerry Clark Group Vice President (President, Laundry and Cleaning Products – North America,
Procter & Gamble North America)
Michael Clasper Group Vice President (President, Laundry Products – Europe, Procter & Gamble Europe,
Middle East and Africa)
Larry G. Dare Group Vice President (President, Paper and Beverage Products – Europe, 
Procter & Gamble Europe, Middle East and Africa)
Stephen P. Donovan, Jr. Group Vice President (President, Food and Beverage Products – North America, 
Procter & Gamble North America)
Jeffrey D. Jones Group Vice President on Special Assignment
Mark D. Ketchum Group Vice President (President, Paper Products – North America, Procter & Gamble
North America)
Fuad O. Kuraytim Group Vice President (President – Middle East, Africa and General Export, 
Procter & Gamble Europe, Middle East and Africa)
Claude L. Meyer Group Vice President – Europe, Middle East and Africa
Martin J. Nuechtern Group Vice President (President – ASEAN and Australasia, Procter & Gamble Asia)
John O’Keeffe Group Vice President (President, Health and Beauty Care Products – Europe, 
Procter & Gamble Europe, Middle East and Africa)
Dimitri Panayotopoulos Group Vice President (President – China, Procter & Gamble Asia)
Herbert Schmitz Group Vice President (President – Central and Eastern Europe, Procter & Gamble
Europe, Middle East and Africa)
Clayton C. Daley, Jr. Vice President and Treasurer
David R. Walker Vice President and Comptroller
Terry L. Overbey Secretary and Associate General Counsel
Organization Changes
The following changes in the senior management of the Company were announced during the past year:
Benjamin L. Bethell, Edwin H. Eaton, Jr., and Lawrence D. Milligan retired.
Richard L. Antoine and Stephen N. David were elected Senior Vice Presidents.
Brian J. Buchan and Michael Clasper were elected Group Vice Presidents.
Jacobus Groot resigned from the Company.
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If . . .
• You need help with your account or if you need
automated access to your account
• You are interested in our Certificate Safekeeping service
• You need to change an address or discontinue
duplicate mailings
• You want to arrange for direct deposit of dividends
• A stock certificate is lost, stolen or destroyed
• You want to participate in our Shareholder
Investment Program . . .
Contact P&G’s Shareholder Services 
Office in Cincinnati.
Call: 1-800-742-6253
1-513-983-3034 (outside the U.S.)
Write: The Procter & Gamble Company
Shareholder Services Department
P.O. Box 5572
Cincinnati, Ohio 45201-5572
Financial information is available 24 hours a day. Just
call 1-800-764-7483.
You can also visit us on the World Wide Web. Our
address is www.pg.com/investor
Common Stock Price Range and Dividends
Price Range Dividends
- - - -
Quarter Ended High Low High Low
September 30 $77.56 $64.06 $48.75 $41.19 $.2525 $.2250
December 31 83.44 62.00 55.50 45.75 .2525 .2250
March 31 87.88 77.31 64.81 51.81 .2525 .2250
June 30 92.50 80.19 71.94 56.63 .2525 .2250
Corporate Headquarters
The Procter & Gamble Company
P.O. Box 599
Cincinnati, Ohio 45201-0599
Transfer Agent/Shareholder Services
The Procter & Gamble Company
Shareholder Services Department
P.O. Box 5572
Cincinnati, Ohio 45201-5572
Registrar
PNC Bank, N.A.
P.O. Box 1198
Cincinnati, Ohio 45201-1198
Exchange Listing
New York, Cincinnati, Amsterdam, Paris, Basle,
Geneva, Lausanne, Zurich, Frankfurt, Brussels, Tokyo
Shareholders of Common Stock
There were 272,723 Common Stock shareholders of
record, including participants in the Shareholder
Investment Program, as of July 24, 1998.
Form 10-K
Beginning in October 1998, shareholders may obtain a
copy of the Company’s 1998 report to the Securities
and Exchange Commission on Form 10-K by going to
P&G’s investor Web site at www.pg.com/investor or by
calling us at 1-800-742-6253. This information is also
available at no charge by sending a request to
Shareholder Services at the address above.
Shareholders’ Meeting
The next annual meeting of shareholders will be held
on Tuesday, October 13, 1998. A full transcript of the
meeting will be available from Linda D. Rohrer,
Assistant Secretary, at a cost of $10. Ms. Rohrer can
be reached at One P&G Plaza, Cincinnati, Ohio
45202-3315.
We make the brands you trust every day.
Features available for you on: 
• Sign up to receive P&G earnings and 
dividend news releases via e-mail
• Receive future annual reports and proxy
statements online
• Automatically update all of your personal
investments with the latest prices
• Moving? Change your address
• Find our latest stock price
• Print forms to transfer shares, 
make optional cash payments and 
reinvest dividends
We are constantly striving to 
improve the quality of service for 
our Shareholders. You can now 
vote P&G’s proxy online – see the
enclosed proxy card for more detail.
The Procter & Gamble Company  One Procter & Gamble Plaza  Cincinnati, Ohio  452020038-7103
Vote P&G’s proxy online
• Read stock market commentary every 
trading day
• Find answers to the most frequently asked
shareholder questions
• Discover P&G’s historical stock 
performance versus the S&P 500
• Find 5 to 10 years worth of key financial
performance measures, such as operating
margin and return on equity
• Review daily stock prices over the 
last 30 years 
• Print a direct stock purchase plan 
application
http://www.pg.com/investor
